Annual Working Capital
$159.85 M
+$151.52 M+1818.08%
31 December 2023
Summary:
Soleno Therapeutics annual working capital is currently $159.85 million, with the most recent change of +$151.52 million (+1818.08%) on 31 December 2023. During the last 3 years, it has risen by +$145.44 million (+1008.94%). SLNO annual working capital is now at all-time high.SLNO Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$243.24 M
-$15.12 M-5.85%
30 September 2024
Summary:
Soleno Therapeutics quarterly working capital is currently $243.24 million, with the most recent change of -$15.12 million (-5.85%) on 30 September 2024. Over the past year, it has increased by +$83.38 million (+52.16%). SLNO quarterly working capital is now -5.85% below its all-time high of $258.35 million, reached on 30 June 2024.SLNO Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SLNO Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +52.2% |
| 3 y3 years | +1008.9% | +1587.4% |
| 5 y5 years | +888.0% | +1403.3% |
SLNO Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1818.1% | -5.8% | >+9999.0% |
| 5 y | 5 years | at high | +1818.1% | -5.8% | >+9999.0% |
| alltime | all time | at high | +1363.2% | -5.8% | +1875.0% |
Soleno Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $243.24 M(-5.9%) |
| June 2024 | - | $258.35 M(+87.5%) |
| Mar 2024 | - | $137.76 M(-13.8%) |
| Dec 2023 | $159.85 M(+1818.1%) | $159.85 M(+548.1%) |
| Sept 2023 | - | $24.67 M(+110.8%) |
| June 2023 | - | $11.70 M(+756.5%) |
| Mar 2023 | - | $1.37 M(-83.6%) |
| Dec 2022 | $8.33 M(-42.2%) | $8.33 M(-37.0%) |
| Sept 2022 | - | $13.23 M(-25.0%) |
| June 2022 | - | $17.64 M(-22.2%) |
| Mar 2022 | - | $22.66 M(+57.2%) |
| Dec 2021 | $14.41 M(-65.4%) | $14.41 M(-27.4%) |
| Sept 2021 | - | $19.84 M(-24.2%) |
| June 2021 | - | $26.18 M(-20.7%) |
| Mar 2021 | - | $33.02 M(-20.7%) |
| Dec 2020 | $41.63 M(+157.3%) | $41.63 M(-14.2%) |
| Sept 2020 | - | $48.49 M(-11.3%) |
| June 2020 | - | $54.64 M(+554.0%) |
| Mar 2020 | - | $8.36 M(-48.4%) |
| Dec 2019 | $16.18 M | $16.18 M(+98.4%) |
| Sept 2019 | - | $8.15 M(-40.7%) |
| June 2019 | - | $13.76 M(-26.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $18.61 M(-18.3%) |
| Dec 2018 | $22.79 M(+40.2%) | $22.79 M(+156.0%) |
| Sept 2018 | - | $8.90 M(-21.7%) |
| June 2018 | - | $11.37 M(-18.0%) |
| Mar 2018 | - | $13.87 M(-14.7%) |
| Dec 2017 | $16.26 M(+676.6%) | $16.26 M(+249.0%) |
| Sept 2017 | - | $4.66 M(-43.2%) |
| June 2017 | - | $8.20 M(-14.9%) |
| Mar 2017 | - | $9.63 M(+359.8%) |
| Dec 2016 | $2.09 M(-34.8%) | $2.09 M(-55.7%) |
| Sept 2016 | - | $4.73 M(+155.0%) |
| June 2016 | - | $1.85 M(-62.9%) |
| Mar 2016 | - | $5.00 M(+55.8%) |
| Dec 2015 | $3.21 M(-54.4%) | $3.21 M(-739.8%) |
| Sept 2015 | - | -$502.00 K(-90.3%) |
| June 2015 | - | -$5.18 M(-157.8%) |
| Mar 2015 | - | $8.96 M(+27.2%) |
| Dec 2014 | $7.05 M(-155.7%) | $7.05 M(-646.8%) |
| Sept 2014 | - | -$1.29 M(-389.3%) |
| June 2014 | - | $445.60 K(-103.3%) |
| Mar 2014 | - | -$13.70 M(+8.3%) |
| Dec 2013 | -$12.65 M(+38.2%) | -$12.65 M |
| Dec 2012 | -$9.15 M | - |
FAQ
- What is Soleno Therapeutics annual working capital?
- What is the all time high annual working capital for Soleno Therapeutics?
- What is Soleno Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Soleno Therapeutics?
- What is Soleno Therapeutics quarterly working capital year-on-year change?
What is Soleno Therapeutics annual working capital?
The current annual working capital of SLNO is $159.85 M
What is the all time high annual working capital for Soleno Therapeutics?
Soleno Therapeutics all-time high annual working capital is $159.85 M
What is Soleno Therapeutics quarterly working capital?
The current quarterly working capital of SLNO is $243.24 M
What is the all time high quarterly working capital for Soleno Therapeutics?
Soleno Therapeutics all-time high quarterly working capital is $258.35 M
What is Soleno Therapeutics quarterly working capital year-on-year change?
Over the past year, SLNO quarterly working capital has changed by +$83.38 M (+52.16%)